Aclaris Therapeutics Quote - ACRS

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

2.85

Bid

2.73

Ask

3.05

Volume

539,571

2.71 Day's Range 2.96

0.8555 52 Week Range 5.17

Market Cap

203.578M

Previous Close

2.915

Open

2.96

Last Trade

2.8

Last Trade Time

18:52:11

Financial Volume

US$ 1,500,442

VWAP

2.7808

Average Volume (3m)

2,584,407

Shares Outstanding

71,430,942

Dividend Yield

PE Ratio

-2.20

Earnings Per Share (EPS)

-1.24

Revenue

31.25M

Net Profit

-88.48M

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from... Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aclaristx.com

Headquarters

Wilmington, Delaware, USA

Founded

Aclaris Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ACRS. The last closing price for Aclaris Therapeutics was US$2.92. Over the last year, Aclaris Therapeutics shares have traded in a share price range of US$ 0.8555 to US$ 5.17.

Aclaris Therapeutics currently has 71,430,942 shares outstanding. The market capitalization of Aclaris Therapeutics is US$208.22 million. Aclaris Therapeutics has a price to earnings ratio (PE ratio) of -2.20.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.11	4.01459854015	2.74	3.12	2.71	1053799	2.84897623	CS
4	-1.01	-26.1658031088	3.86	4.24	2.71	974594	3.37911238	CS
12	1.65	137.5	1.2	5.17	1.12	2584407	3.58109732	CS
26	1.73	154.464285714	1.12	5.17	1.1	1490665	3.12668879	CS
52	1.82	176.699029126	1.03	5.17	0.8555	1360090	2.24621214	CS
156	-12.47	-81.3968668407	15.32	18.9583	0.5902	1184748	4.74031697	CS
260	1.01	54.8913043478	1.84	30.375	0.5902	1056402	7.58413596	CS

ACRS - Frequently Asked Questions (FAQ)

What is the current Aclaris Therapeutics share price?

The current share price of Aclaris Therapeutics is US$ 2.85

How many Aclaris Therapeutics shares are in issue?

Aclaris Therapeutics has 71,430,942 shares in issue

What is the market cap of Aclaris Therapeutics?

The market capitalisation of Aclaris Therapeutics is USD 208.22M

What is the 1 year trading range for Aclaris Therapeutics share price?

Aclaris Therapeutics has traded in the range of US$ 0.8555 to US$ 5.17 during the past year

What is the PE ratio of Aclaris Therapeutics?

The price to earnings ratio of Aclaris Therapeutics is -2.2

What is the cash to sales ratio of Aclaris Therapeutics?

The cash to sales ratio of Aclaris Therapeutics is 6.24

What is the reporting currency for Aclaris Therapeutics?

Aclaris Therapeutics reports financial results in USD

What is the latest annual turnover for Aclaris Therapeutics?

The latest annual turnover of Aclaris Therapeutics is USD 31.25M

What is the latest annual profit for Aclaris Therapeutics?

The latest annual profit of Aclaris Therapeutics is USD -88.48M

What is the registered address of Aclaris Therapeutics?

The registered address for Aclaris Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Aclaris Therapeutics website address?

The website address for Aclaris Therapeutics is www.aclaristx.com

Which industry sector does Aclaris Therapeutics operate in?

Aclaris Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Symbol	Price	Vol.
VINCVincerx Inc	US$ 0.32 (64.95%)	23.04M
AERTAeries Technology Inc	US$ 1.39 (58.51%)	1.96M
CCTGCCSC Technology International Holdings Ltd	US$ 2.45 (49.39%)	3.11M
ARTWArts Way Manufacturing Co Inc	US$ 3.28 (34.43%)	242.28k
VRPXVirpax Pharmaceuticals Inc	US$ 0.501 (22.20%)	2.26M
LITMSnow Lake Resources Ltd	US$ 1.10 (-31.25%)	9.69M
XAIRBeyond Air Inc	US$ 0.38 (-13.64%)	1.9M
SHMDSCHMID Group NV	US$ 2.75 (-12.42%)	24.28k
COEPCoeptis Therapeutics Holdings Inc	US$ 0.1601 (-12.13%)	340.97k
AVGRAvinger Inc	US$ 0.85 (-11.92%)	271.51k
VINCVincerx Inc	US$ 0.32 (64.95%)	23.04M
CEROCERo Therapeutics Holdings Inc	US$ 0.0628 (4.67%)	15.27M
XTIAXTI Aerospace Inc	US$ 0.0414 (4.81%)	13.19M
LITMSnow Lake Resources Ltd	US$ 1.10 (-31.25%)	9.69M
INTZIntrusion Inc	US$ 1.94 (-10.19%)	7.78M

Symbol

Price

Vol.